Untersuchungen zum hereditären Angioödem im deutschsprachigen Raum

[1]  A. Davis,et al.  Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability‐enhancing activities , 1994, Clinical and experimental immunology.

[2]  R. Perricone,et al.  Cystic ovaries in women affected with hereditary angioedema , 1992, Clinical and experimental immunology.

[3]  M. Cicardi,et al.  Replacement therapy in hereditary and acquired angioedema. , 1992, Pharmacological research.

[4]  M. Cicardi,et al.  Hereditary and Acquired C1‐Inhibitor Deficiency: Biological and Clinical Characteristics in 235 Patients , 1992, Medicine.

[5]  E. Hack,et al.  Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience. , 1991, The Journal of allergy and clinical immunology.

[6]  M. Cicardi,et al.  Contraindications to the use of ace inhibitors in patients with C1 esterase inhibitor deficiency. , 1991, The American journal of medicine.

[7]  J. Hardie,et al.  Potentially fatal hereditary angioedema: a review and case report. , 1990, Journal.

[8]  M. Frank,et al.  The long-term safety of danazol in women with hereditary angioedema. , 1990, Fertility and sterility.

[9]  J. A. Grant,et al.  Hereditary angioedema: its diagnostic and management perspectives. , 1990, The American journal of medicine.

[10]  E. Hack,et al.  Plasma levels of C1- inhibitor complexes and cleaved C1- inhibitor in patients with hereditary angioneurotic edema. , 1990, The Journal of clinical investigation.

[11]  J. Leoni,et al.  Hereditary angioedema: therapeutic effect of danazol on C4 and C1 esterase inhibitors. , 1990, Annals of allergy.

[12]  B. Wüthrich,et al.  Angioedema. A review on the acquired, allergic or non-allergic, and the hereditary forms. , 1990, Recenti progressi in medicina.

[13]  R. Lehner,et al.  Recurrent angioedema associated with hypogonadism or anti-androgen therapy. , 1989, Annals of allergy.

[14]  K. Bork,et al.  Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency. , 1989, The Journal of allergy and clinical immunology.

[15]  B. Zweiman,et al.  Pathways of kinin formation and role in allergic diseases. , 1989, Clinical immunology and immunopathology.

[16]  Ó. Håkansson.  Menstruation‐related angioedema treated with tranexamic acid , 1988, Acta obstetricia et gynecologica Scandinavica.

[17]  P. Poppers.  Anaesthetic implications of hereditary angioneurotic oedema , 1987, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[18]  W. Cunliffe,et al.  Recurrent angioedema: familial and oestrogen‐induced , 1986, The British journal of dermatology.

[19]  G. Tsokos,et al.  Immunoregulatory disorders associated with hereditary angioedema. I. Clinical manifestations of autoimmune disease. , 1986, The Journal of allergy and clinical immunology.

[20]  G. Andriole,et al.  Danazol-induced cystitis: an undescribed source of hematuria in patients with hereditary angioneurotic edema. , 1986, The Journal of urology.

[21]  B. Lämmle,et al.  Cold Promoted Activation and Factor XII, Prekallikrein and C1-Inhibitor , 1985, Thrombosis and Haemostasis.

[22]  M. Cicardi,et al.  C1 INH Concentrate in the Therapy of Hereditary Angioedema , 1983, Allergy.

[23]  O. Ratnoff,et al.  Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives. , 1980, The Journal of laboratory and clinical medicine.

[24]  J. Gelfand,et al.  Response of variant hereditary angioedema phenotypes to danazol therapy. Genetic implications. , 1979, The Journal of clinical investigation.

[25]  K. Pritzker,et al.  Hereditary angioneurotic edema: an unusual case of maternal mortality. , 1979, Journal of forensic sciences.

[26]  J. Atkinson,et al.  Hereditary angioedema: the clinical syndrome and its management. , 1976, Annals of internal medicine.

[27]  D. Alling,et al.  Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. , 1976, The New England journal of medicine.